During the past decade, Baylor College of Medicine, Alkek Eye Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor College of Medicine, Alkek Eye Center" #1 sponsor was "Abbott Medical Optics" with 1 trials, followed by "Allergan" with 1 trials sponsored, "Applied Genetic Technologies Corp" with 1 trials sponsored, "Baylor College of Medicine" with 1 trials sponsored and "Benjamin Frankfort, MD, PhD" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine, Alkek Eye Center" #1 collaborator was "Foundation Fighting Blindness" with 1 trials as a collaborator, "HumanOptics AG" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine, Alkek Eye Center" are "Cataract" (1 trials), "Dry Eye Syndrome" (1 trials), "Full Aniridia" (1 trials), "Glaucoma" (1 trials) and "Glaucoma and Ocular Hypertension" (1 trials). Many other conditions were trialed in "Baylor College of Medicine, Alkek Eye Center" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine, Alkek Eye Center" are "Drug" (6 trials), "Device" (3 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator: Timolol 0.5%" (1 trials), "Artificial Iris (CustomFlex)" (1 trials), "Artificial tear" (1 trials), "Bimatoprost SR" (1 trials) and "DE-117 Ophthalmic Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine, Alkek Eye Center" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Baylor College of Medicine, Alkek Eye Center". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Baylor College of Medicine, Alkek Eye Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine, Alkek Eye Center, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".